Close Menu

NEW YORK (GenomeWeb) – Canadian diagnostics firm Med BioGene (MBI) has announced a settlement with Helomics, eliminating or revising several terms of a 2011 licensing agreement between the two firms.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.